戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 hilic and hydrophobic cargos within a single microcapsule.
2 from two different locations within the same microcapsule.
3 sequestered within a permeable, charged-film microcapsule.
4 es (CPN) were incorporated into PNA hydrogel microcapsule.
5  co-microcapsules than the oil released from microcapsules.
6 better thermal stability of resistant starch microcapsules.
7 s in yogurts protected using MTGase-mediated microcapsules.
8 oss-linking ability of laccase, or CaCl2, on microcapsules.
9 em as templates to fabricate polyelectrolyte microcapsules.
10 ructure than the lentil protein-maltodextrin microcapsules.
11 f small molecules and active biomolecules in microcapsules.
12 ignificantly higher MEEs than those of GE-AG microcapsules.
13 lyoxypropylenetriamine into hollow polymeric microcapsules.
14  ferric reducing power than did whey protein microcapsules.
15 f Saccharomyces boulardii within spray dried microcapsules.
16 and aid in the generation of multifunctional microcapsules.
17 its the survivability of S. boulardii within microcapsules.
18 e-glutamine degradable polylysine (A-GD-PLL) microcapsules.
19 oxidant molecules was observed in gum arabic microcapsules.
20 t for the elasticity and osmotic collapse of microcapsules.
21 mer shell in the form of aqueous dispersible microcapsules.
22 bserved in spray-dried double emulsion (SDE) microcapsules.
23 in we report a general route to programmable microcapsules.
24 cantly affect retention of bioactives in the microcapsules.
25 c and intestinal fluids predominated for FDE microcapsules.
26 ibution of CSO on the surface and within the microcapsules.
27 tween populations of non-lipid semipermeable microcapsules.
28 the surface and in the interior of the solid microcapsules.
29 ounds and to improve the thermal behavior of microcapsules.
30 emical images obtained from each type of the microcapsules.
31  resin modified with anisole and PMMA-filled microcapsules.
32                                  2AP-ZnCl(2) microcapsules (0.081% (w/w) 2AP loading) and unprotected
33                                          The microcapsules (13-42mum) promoted protection against oil
34 histological analysis reveals a safe dose of microcapsules (20 x 10(6)), which has not lead to irreve
35 sed to incorporate living cells into the PNA microcapsules (~500 um diameter).
36                        For these dual-loaded microcapsules, a programmable and sequential release of
37             However, TEM inspection of these microcapsules after an alcohol challenge revealed no evi
38  of droplet size distribution around 9 mum), microcapsules after spray drying and double emulsions af
39                  Uniform core-shell alginate microcapsules (AMCs), 60-300 mum in diameter, were fabri
40 ng ideas to provide new functionality to the microcapsule and nanocapsule is layer-by-layer depositio
41            Overall, this novel design of PNA microcapsule and the one-step method of cell encapsulati
42       The pattern of release of oil from the microcapsules and co-microcapsules was similar.
43 neered thermogenic response in biocompatible microcapsules and implanted them into the left and right
44         The in-vitro digestibility of the co-microcapsules and microcapsules was studied in terms of
45 Due to the cell-like attributes of polymeric microcapsules and polymersomes, material systems are ava
46 y of encapsulated oil, microstructure of the microcapsules and protection of fatty acids, especially
47 ution with the lowest particle size for both microcapsules and the corresponding emulsions after rehy
48 between the molecule localization inside the microcapsules and the reactivity against the specific re
49 oma cells, HepG2, were encapsulated into the microcapsules and their physio-chemical properties were
50 the microcapsules (W) were evaluated for the microcapsules and two non-encapsulated systems: ethanoli
51      Conventional poly-l-lysine-cross-linked microcapsules and unencapsulated islets were included as
52 ects (e.g., polystyrene beads, drug delivery microcapsules, and living cells) are patterned in respon
53         Intracranially implanted DOX and TMZ microcapsules are compared with systemic administration
54                         The light-responsive microcapsules are composed of photocleavable o-nitrobenz
55 e-modified DNA shells, and the pH-responsive microcapsules are made of a cytosine-rich layer cross-li
56  the autonomous repair of damaged materials, microcapsules are needed that release their contents in
57                                   After 24 h microcapsules are not observed in the target kidney when
58           The size and wall thickness of the microcapsules are precisely controlled.
59                             Hollow composite microcapsules are prepared by the assembly of pre-formed
60                      Polyelectrolyte complex microcapsules are prepared using a novel template- and s
61                                          The microcapsules are produced spontaneously by ultrasonical
62 ure while the alginate and chitosan/alginate microcapsules are spherical with a smooth surface.
63                                          The microcapsules are stable under typical industrial operat
64                                 Although the microcapsules are too large to enter the cracks, their f
65 potential effectiveness of using 2AP-ZnCl(2) microcapsules as a flavoring agent.
66 ior to homogenization led to block copolymer microcapsules, as expected.
67 estimate the half-life of anthocyanin in the microcapsule at room temperature (37 degrees C) clearly
68     Agglomeration of BSO was observed in all microcapsules at pH 4.5 due to slow gelling process and
69 ol) barium sulfate to create barium-alginate microcapsules (BaCaps) that contained hMSCs.
70 n of mechanical damage is achieved through a microcapsule-based polymeric material system.
71 tivity in intact synthetic and biodegradable microcapsules before and after cell delivery as well as
72      We manufactured two new formulations of microcapsules (BioBullets).
73  that intravenous administration of alpha2MG-microcapsules (but not empty microcapsules) promoted neu
74 ts osmotic stress, hence we generated hybrid microcapsules by mixing PEG and ALG (MicroMix) or by coa
75 This study aimed to prepare anthocyanin-rich microcapsules by spray and freeze-drying complex coacerv
76                          The interior of the microcapsule can be loaded with water-soluble hydrophili
77        Moreover, the size selectivity of the microcapsules can be adjusted by changing the type of de
78              These findings suggest that the microcapsules can be applied for loading anthocyanins as
79                                          The microcapsules can be rendered visible during the first s
80   The interfacially assembled supramolecular microcapsules can benefit from the diversity of polymeri
81                           We show that these microcapsules can find the cracks on a surface and selec
82  Due to their geometry and elasticity, these microcapsules can uniquely serve as quantitative mechani
83 S), and the third group consisted of control microcapsules (CM), with no cross-linking.
84 The all-polysaccharide based polyelectrolyte microcapsules combining copigmentation for anthocyanin e
85                                      Polymer microcapsules composed of liquid carbonate cores and hig
86 nt capacities of gum arabic and maltodextrin microcapsules containing antioxidant molecules (trolox,
87 le more rationale layer-by-layer assembly of microcapsules containing biologically active molecules f
88 ication of "photonic pigments" consisting of microcapsules containing dense amorphous packings of cor
89 nsport and simultaneously rupturing adjacent microcapsules containing gallium-indium liquid metal (to
90 n efficiency was high (>=89%) and oil within microcapsules containing MC exhibited higher (p < 0.05)
91 , conjugated dienes increased more slowly in microcapsules containing MC.
92 brane emulsification (ME) enabled to produce microcapsules containing procyanidins.
93                 Fish oil was loaded into the microcapsule core and protected with a shell composed of
94 olic activity, indicating that the 3D PNA-10 microcapsule could be suitable to maintain better vitali
95                                           GG microcapsules could be readily visualized with positive-
96 n of the membrane building blocks to produce microcapsules covered in a chemically distinct, dense ne
97 with laccase (MCL), the second group was the microcapsules cross-linked with divalent cationic CaCl2
98                      The first group was the microcapsules cross-linked with laccase (MCL), the secon
99                                      The two microcapsule DEET formulations exhibited 36-40% higher c
100 rom the PLGA-GLN pellet resulted in A-GD-PLL microcapsule degradation and eventual PC12 cell death fo
101                                      Uneaten microcapsules degrade and become biologically inactive w
102                                        These microcapsule devices provide a safe, reliable vehicle fo
103 ore effective than soluble alpha2MG or empty microcapsules (devoid of active protein).
104  hydrogel-layer (~150 nm) provides the inner microcapsule (diameter ~2.5 mum).
105                        Injection of non-safe microcapsule dose leads to carriers staying in glomeruli
106  encapsulation efficiency was higher for LBL microcapsules (e.g. 99.6 +/- 0.4% for 2.5% citral) than
107 ainst the test microorganisms compared to IN microcapsules, especially at concentrations of 100mg/mL.
108                                 The chitosan microcapsules exhibited the maximum release rate at pH 2
109 um release rate at pH 2.5 while the alginate microcapsules exhibited the maximum release rate at pH 6
110               We show that the design of the microcapsules facilitates the suppression of incoherent
111                 In this approach, a flexible microcapsule filled with a solution of nanoparticles rol
112 tudy was to produce and characterise xylitol microcapsules for use in foods, in order to prolong the
113  into chitosan-calcium alginate double layer microcapsules, for the production of a Pale Ale beer.
114 g the chitosan-calcium alginate double layer microcapsules, for the production of Riesling sparkling
115 ops, which can then be used as templates for microcapsule formation.
116                                              Microcapsules, formed by employing these experimental co
117 ws from the surface toward the center of the microcapsule, forming an onion-like arrangement.
118 ulations were studied: a previously reported microcapsule formulation (Formulation A); a newly-develo
119 rmulation (Formulation A); a newly-developed microcapsule formulation (Formulation B); and a non-enca
120                          Hence, colloidosome microcapsule formulations successfully provide good prot
121                                  Spray-dried microcapsules from double (DM) and multilayered (MM) fis
122 c resonance (TD-NMR) were applied to analyse microcapsules glass transition temperature (Tg).
123 to those observed for the other two types of microcapsules (&gt;5%, w/w).
124                                 The chitosan microcapsules had a brain-like structure while the algin
125               The complex coacervation based microcapsules had a significantly lower oil content (~2%
126                                 Whey protein microcapsules had comparably lower release rates but hig
127        During in vitro digestion, gum arabic microcapsules had high release rates of phenolics with h
128                  The results showed that the microcapsules had significantly greater 2AP stability co
129 mbly of metal-organic frameworks (MOFs) into microcapsules has attracted great interest because of th
130                          The prepared MOF/CW microcapsules have excellent stability and enable the st
131               The resulting BCNU-loaded PLGA microcapsules have significantly higher drug encapsulati
132                     Layer-by-layer assembled microcapsules have the potential to be versatile cell de
133 idics can be used to fabricate solid-shelled microcapsules having precisely controlled release behavi
134 s for the assembly of the shell of nano- and microcapsules holds great promise for the tailor-made de
135 partial pressure of oxygen (pO2) in alginate microcapsules implanted intraperitoneally in healthy non
136  for one-step fabrication of polyelectrolyte microcapsules in aqueous conditions.
137 phology, size, and chemical structure of PNA microcapsules in cell culture media.
138 ver, we demonstrate the application of these microcapsules in encapsulation and release of proteins w
139 ucibly mitigate the CO of implanted alginate microcapsules in mice, dogs and pigs.
140                 It was possible to apply the microcapsules in yogurt, without compromising the rheolo
141                 In addition, a pH-responsive microcapsule-in-microcapsule system is loaded with gluco
142                     The acidification of the microcapsule-in-microcapsule system leads to the trigger
143 layer (thickness of ~150 nm) that yields the microcapsule-in-microcapsule system.
144 nsive nucleic acid-based hydrogel-stabilized microcapsule-in-microcapsule systems is introduced.
145 this work also demonstrates the inclusion of microcapsules into 3D printing resins to incorporate add
146 r/antioxidant), and incorporate the obtained microcapsules into yogurt.
147 a dual-function nanoparticle-loaded hydrogel microcapsule is developed that enables graft retrieval u
148                                    The inner microcapsule is separated from an outer aqueous compartm
149     The formulation of these probiotics into microcapsules is an emerging method to reduce cell death
150 ng how an advancing crack interacts with the microcapsules is critical to optimizing performance thro
151 Although many techniques exist for preparing microcapsules, it is still challenging to fabricate them
152 g the o-nitrobenzyl phosphate-functionalized microcapsules, lambda = 365 nm, or subjecting the pH-res
153 by sodium caseinate alone and layer-by-layer microcapsules (LBL) stabilized by sodium caseinate and p
154 lsions and the characteristics of CEO-loaded microcapsules like morphology, moisture, wettability, so
155 ending recent observations made with dextran-microcapsules loaded with alpha2MG in experimental sepsi
156 o assemble light-responsive or pH-responsive microcapsules loaded with different loads (tetramethylrh
157  is presented to optimize the formulation of microcapsules loaded with labile compounds.
158 ioluminescent enzyme luciferase in different microcapsule locations has on activity in intact synthet
159 t and bioaccessibility, the type of fish oil microcapsules may be selected as a function of the type
160 ffects of transplanting alginate (ALG)-based microcapsules (Micro) in the confined and well-vasculari
161 different emulsifier compositions: monolayer microcapsules (ML) stabilized by sodium caseinate alone
162                           WPI-CMC stabilized microcapsules not only showed the highest procyanidin co
163    Particle size analysis indicated that the microcapsules obtained had a mean particle size of 60.97
164                The optimized co-encapsulated microcapsules obtained in this work showed an improved b
165                                          The microcapsules obtained under optimal conditions were sto
166                                              Microcapsules obtained using the optimized combination o
167                                          The microcapsules obtained were characterised in terms of pa
168 application of spray-chilled paraffin-coated microcapsules of 2AP zinc chloride complex (2AP-ZnCl(2))
169                                Additionally, microcapsules of mucilage achieved the retention of beta
170                                     Solid co-microcapsules of omega-3 rich tuna oil and probiotic bac
171 on the physical and structural properties of microcapsules of pure carrot juice.
172                                          The microcapsules of xylitol showed desirable characteristic
173        Compared with nonfluorinated alginate microcapsules, PFOB fluorocapsules increased insulin sec
174 ulated using hyperbarically-loaded polymeric microcapsules (PMC).
175                We also examine the effect of microcapsule position on cell transfection with plasmid
176           Freeze-dried double emulsion (FDE) microcapsules possessed higher total anthocyanin and tot
177 io (HR=1.38-1.44) values showed that all the microcapsules prepared correspond to the "poor" flowabil
178                        The yogurt containing microcapsules, presented a pH range from 3.89 to 4.17 an
179                                          The microcapsules produced are extremely monodisperse in siz
180                               Among four PNA microcapsule products (PNA-0, PNA-10, PNA-30, and PNA-50
181                     We present a new type of microcapsule programmed with a tunable active release me
182 ion of alpha2MG-microcapsules (but not empty microcapsules) promoted neutrophil migration into perito
183                      Initially, emulsion and microcapsule properties as a function of oil (20%-30%),
184 umin (OVA) and sodium alginate (AL), and the microcapsule properties were characterized.
185 aterials, allowing for fine control over the microcapsule properties.
186 coacervate microdroplets and protein-polymer microcapsules (proteinosomes) that interact via electros
187                                 The A-GD-PLL microcapsules provided a 3-D microenvironment for good s
188 crofluidics to produce monodisperse polyurea microcapsules (PUMC) with a limonene core.
189             Upon mechanical damage, ruptured microcapsules release a liquid indicator molecule.
190                In the simulations, signaling microcapsules release agonist particles, whereas target
191 es release agonist particles, whereas target microcapsules release antagonist particles and the perme
192                    We have demonstrated that microcapsules released Lf in small intestine allowing 6.
193 m 39% to 85% for gum arabic and maltodextrin microcapsules, respectively, suggesting that this carote
194 rst-order and Higuchi models for SDE and FDE microcapsules, respectively.
195                                   The inulin microcapsules retained 94.1% of its antioxidant capacity
196                        Rehydrated gum arabic microcapsules retained more total ACNs but less ferric r
197                                     All wine microcapsules revealed significant activity against medi
198 ns (3D) the dynamic process of crack growth, microcapsule rupture and progressive release of solvent
199 tal oxidation (Totox): 26.5), followed by SD microcapsules (SD-M) (34.9) and RPO (56.7).
200                                         SEDS microcapsules (SEDS-M) were the most oxidatively stable
201 t, the anisotropic single-crystal-containing microcapsules selectively display-at certain orientation
202 anocarriers for hydrophobic molecules in the microcapsule shell.
203  to pH = 5.0, results in the cleavage of the microcapsule shells and the release of the loads.
204                                        These microcapsules show non-iridescent structural colors that
205                                      The SIO microcapsules showed a high encapsulation efficiency of
206     The lentil protein-maltodextrin-alginate microcapsules showed better oxidative stability and had
207                                    The empty microcapsules showed capacity to scavenge all the studie
208                                          The microcapsules showed high stability in gastric condition
209 r transform infrared (FT-IR) spectroscopy of microcapsules showed peaks in the region of 900-1300cm(-
210                                       CS-CMS microcapsules showed significantly higher MEEs than thos
211 t the antibacterial activity of the obtained microcapsules significantly depends on both citral conce
212 ater activity, moisture and oil content, and microcapsule size distribution was investigated.
213  to trap a small hydrophilic molecule in the microcapsule skin as cargo.
214  aim of this work was to produce solid lipid microcapsules (SLMs) loaded with AA using microfluidic t
215 ological characterization indicated that the microcapsules so obtained were oval to round in shape an
216 omitant increase in oil droplet diameter and microcapsule surface oil content, and a decrease in oil
217 In addition, a pH-responsive microcapsule-in-microcapsule system is loaded with glucose oxidase (GOx)
218     The acidification of the microcapsule-in-microcapsule system leads to the triggered unlocking of
219         Self-healing is achieved with a dual-microcapsule system utilizing epoxy-amine chemistry in a
220  of ~150 nm) that yields the microcapsule-in-microcapsule system.
221 id-based hydrogel-stabilized microcapsule-in-microcapsule systems is introduced.
222 anthocyanin retention during storage for all microcapsules tested.
223 acids was higher in the oil released from co-microcapsules than the oil released from microcapsules.
224      This protocol details methods to create microcapsules that are visible by X-ray, ultrasound (US)
225 ical processing ensures allergen-free pollen microcapsules that can be loaded with vaccine antigens.
226  we develop models for a colony of synthetic microcapsules that communicate by producing and releasin
227 l modeling, we design colonies of biomimetic microcapsules that exploit chemical mechanisms to commun
228 cles with EDTA yields the stimuli-responsive microcapsules that include the respective loads.
229        The use of this approach to fabricate microcapsules that only release their contents when expo
230                         The type of fish oil microcapsules, the processing and/or culinary cooking an
231                                  Tocotrienol microcapsules (TM) were formed by firstly preparing Pick
232 e applied dextran-based layer-by-layer (LbL) microcapsules to deliver alpha-2-macroglobulin (alpha2MG
233 olayered (MO) and multilayered (MU) fish oil microcapsules to meat model systems and determines the e
234 by create adhesion gradients that propel the microcapsules to move.
235 da = 365 nm, or subjecting the pH-responsive microcapsules to pH = 5.0, results in the cleavage of th
236   Selective cytotoxicity of the DOX-D-loaded microcapsules toward cancer cells is demonstrated.
237 address the cytotoxicity of the DOX-D-loaded microcapsules toward MDA-MB-231 breast cancer cells and
238 unosuppression, but thus far islets in large microcapsules transplanted in the peritoneal cavity have
239             Nevertheless, samples containing microcapsules up to 5%wt were not distinguished from the
240                              Methods to make microcapsules - used in a broad range of healthcare and
241 ing tocotrienols, which was then gelled into microcapsules using alginate and chitosan.
242 Thus, the formulation of these bacteria into microcapsules using appropriate biomaterials is a promis
243   Microencapsulation efficiency (MEE) of the microcapsules varied from 84.9% to 94.7%.
244  ferric reducing antioxidant activity of the microcapsules (W) were evaluated for the microcapsules a
245 f nanoparticles is made possible by the thin microcapsule wall (comparable to the diameter of the nan
246 M) revealed that the internal surface of the microcapsule was honeycomb-like networks containing nonh
247 t activity of the intestinal fluids when the microcapsule was spray-dried with pure W.
248 where the controlled release function of the microcapsules was clearly exhibited.
249 release of oil from the microcapsules and co-microcapsules was similar.
250 ro digestibility of the co-microcapsules and microcapsules was studied in terms of survival of L. cas
251 g time, TOTOX values of SDASO in MRP-derived microcapsules were 29-87% lower than that of the non-cro
252 rried out every 15 days, and the most stable microcapsules were achieved with maltodextrin DE(4-7) pr
253                                          The microcapsules were also additionally analyzed for the pa
254 ability, and chemical composition of the PNA microcapsules were analysed by light microscopy, fluores
255                                     Thirteen microcapsules were analysed by scanning electron microsc
256 and droplet size distribution of redispersed microcapsules were analyzed.
257 tal oil ratios in all the three types of the microcapsules were closely similar to the original non-p
258 ed on the surface and in the interior of the microcapsules were compared based on the average spectra
259 n were preloaded in CaCO3 scaffold, and then microcapsules were created by coating the sacrificial Ca
260 nanofibre-integrated alginate (PNA) hydrogel microcapsules were designed using NIM technology.
261 oxidant capacity and color difference of the microcapsules were determined.
262                                          The microcapsules were evaluated for particle size, accelera
263                                          The microcapsules were evaluated structurally with respect t
264 roperties and release characteristics of the microcapsules were evaluated.
265                                          The microcapsules were formed using two different microfluid
266                                   Multi-core microcapsules were formed when the mixed microencapsulat
267                                          The microcapsules were further classified into three sub-gro
268 ween aggregates of 0.5-mm or 1.5-mm alginate microcapsules were identified in vivo by looking at thei
269                                          The microcapsules were loaded with Cur up to about 55% w/w w
270 an macrophage phagocytosis: in both settings microcapsules were more effective than soluble alpha2MG
271    The effect of cross-linking agents on the microcapsules were more significant when the microcapsul
272 vels of anthocyanin losses in blueberry wine microcapsules were much greater: 19.9% (HP-beta-CD) and
273                                          The microcapsules were multinucleated, not very water-solubl
274 s showed that spherical nano-, submicro- and microcapsules were obtained through both techniques, alt
275                                Blueberry ACN microcapsules were prepared from two wall materials (whe
276                                          The microcapsules were prepared with two different emulsifie
277 microcapsules were more significant when the microcapsules were produced by microfluidics.
278           In this study, chia seed oil (CSO) microcapsules were produced using three types of shell m
279 tivities of blackcurrant and chokeberry wine microcapsules were stable and remained unchanged during
280                                          The microcapsules were subsequently placed within a poly(eth
281 bited a SICA effect when the cPPA core-shell microcapsules were suspended in ion-containing acidic me
282      Significant amounts of Lf released from microcapsules were then absorbed into bloodstream and ac
283 al characteristics and microstructure of the microcapsules, were investigated.
284  an efficient encapsulation of alpha2MG into microcapsules, which enhanced i) human leukocyte recruit
285 he simulated gastric fluid was found for SDE microcapsules, while erosion-controlled release in simul
286 observations, we developed cPPA programmable microcapsules whose payload release rates depend on the
287   Specifically, the creation of a bimetallic microcapsule with controlled payload release and precise
288                                              Microcapsules with 20% oil, 2% protein and 18% maltodext
289                                    Polymeric microcapsules with a light-absorbing dye incorporated in
290 ds from bilberries was achieved by designing microcapsules with bilberry seed oil (BSO) distributed i
291 ses microfluidic droplets to generate porous microcapsules with easily customizable functionality.
292 tions and geometrical characteristics of the microcapsules with exceptional precision.
293 dy demonstrated the formulation of oxidative microcapsules with natural materials present in chitosan
294 e progress made so far of bringing nano- and microcapsules with shells of densely packed colloidal pa
295 owever, it remains a challenge to obtain MOF microcapsules with size selectivity at the molecular sca
296 ort materials to assemble MOF/cell wall (CW) microcapsules with size-selective permeability.
297 tions was suitable for spray drying, wherein microcapsules with smooth and spherical morphologies wer
298 ic (GA) coacervates was optimized to produce microcapsules with superior oxidative stability compared
299 epresented the best wall material to produce microcapsules with the highest entrapment efficiency ( a
300 icles (PHMs) are thin-walled, hollow polymer microcapsules with tunable nanoporous shells.
301 epoxy self-healing material, 150 um diameter microcapsules within 400 um of the crack plane are found

 
Page Top